Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Diabetes prevention program outcome study

Trial Profile

Diabetes prevention program outcome study

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Feb 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Metformin (Primary)
  • Indications Glucose intolerance; Hyperglycaemia; Metabolic syndrome; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms DPP; DPPOS
  • Most Recent Events

    • 24 Jan 2020 As per NCT00004992 the trial has been completed. Since the DPP trail is merged with DPPOS so the time period of the study has been increased. And the status is kept active, no longer recruiting as follow up study is ongoing as per results analysis have been followed for an average of 15 years since randomization.
    • 19 Jan 2020 Results (n=2776), assessing the risk of diabetes in women with risk of diabetes infertility and gravidity in diabetes prevention program outcome study (DPPOS) published in the Journal of Clinical Endocrinology and Metabolism
    • 31 Aug 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top